Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Oxford Pharmascience step closer to MAA in sweden for OXPzero Ibuprofen containing OTC
November 20, 2017 Off

Oxford Pharmascience step closer to MAA in sweden for OXPzero Ibuprofen containing OTC

By Dino Mustafić

Oxford Pharmascience has received scientific advice from the MPA (Swedish regulatory authority) about the development programme for future marketing authorisation…

EC approves Novartis’s Tasigna
November 20, 2017 Off

EC approves Novartis’s Tasigna

By Dino Mustafić

The European Commission (EC) has approved Novartis’s Tasigna for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic…

Pneumonia in babies, prevention
November 16, 2017 Off

Pneumonia in babies, prevention

By Dino Mustafić

Pneumonia represents a significant health risk in the very young and very old, and mortality rates remain high among the…

FDA OK’s AstraZeneca’s breast cancer drug
November 15, 2017 Off

FDA OK’s AstraZeneca’s breast cancer drug

By Dino Mustafić

US Food and Drug Administration (FDA) has approved a new indication for AstraZeneca’s Faslodex(fulvestrant), expanding the indication to include use with…

Cardinal Health sells it’s China business to Shanghai Pharmaceuticals for $1.2B
November 15, 2017 Off

Cardinal Health sells it’s China business to Shanghai Pharmaceuticals for $1.2B

By Dino Mustafić

Cardinal Health will sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding for $1.2 billion. 

Hikma buys 6 Boehringer’s products
November 14, 2017 Off

Hikma buys 6 Boehringer’s products

By Dino Mustafić

Hikma Pharmaceuticals has acquired six products from Boehringer Ingelheim GmbH (Boehringer Ingelheim).  

Novartis to present new data about broad range of breast cancer
November 14, 2017 Off

Novartis to present new data about broad range of breast cancer

By Dino Mustafić

Novartis announced it would present data across its breast cancer portfolio and pipeline in a broad range of patient populations,…

Beximco increases comprehensive net income in Q1 2017, ships second product to US
November 14, 2017 Off

Beximco increases comprehensive net income in Q1 2017, ships second product to US

By Dino Mustafić

Beximco Pharmaceuticals last week started the export of Sotalol Hydrochloride, a generic version of the cardiovascular drug Betapace, to the US.

November 14, 2017 Off

Pertinax Pharma appoints ex Sanofi man as new chairman to deal with newly launched Pertinax

By Dino Mustafić

Pertinax Pharma has appointed Nigel Brooksby as chairman of the company. His main task will be the commercialisation of Pertinax,…

Eli Lilly’s Forteo reduces risk for new fractures in postmenopausal women with severe osteoporosis
November 10, 2017 Off

Eli Lilly’s Forteo reduces risk for new fractures in postmenopausal women with severe osteoporosis

By Dino Mustafić

Eli Lilly has reported new data showing that treatment with FORTEO for 24 months was associated with significantly fewer vertebral and clinical…

Posts pagination

Previous 1 … 3,425 3,426 3,427 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine